Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register

Janneke Anink, Marieke H. Otten, Femke H. M. Prince, Esther P. A. H. Hoppenreijs, Nico M. Wulffraat, Joost F. Swart, Rebecca ten Cate, Marion A. J. van Rossum, J. Merlijn van den Berg, Koert M. Dolman, Yvonne Koopman-Keemink, Wineke Armbrust, Sylvia Kamphuis, Philomine A. van Pelt, Simone L. Gorter, Lisette W. A. van Suijlekom-Smit

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)712-717
JournalRheumatology
Volume52
Issue number4
DOIs
Publication statusPublished - Apr 2013

Keywords

  • oligoarticular juvenile idiopathic arthritis
  • etanercept
  • adalimumab
  • response
  • anti-tumour necrosis factor
  • biologic therapy

Cite this